aplastic anemia | Page 18 | Aplastic Anemia & MDS International Foundation

aplastic anemia

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study

Author(s): 
Rogers ZR, Nakano TA, Olson TS, Bertuch AA, Wang W, Gillio A, Coates TD, Chawla A, Castillo P, Kurre P, Gamper C, Bennett CM, Joshi S, Geddis AE, Boklan J, Nalepa G, Rothman JA, Huang JN, Kupfer GM, Cada M, Glader B, Walkovich KJ, Thompson AA, Hanna R
Primary Author: 
Rogers ZR
Journal Title: 
Haematologica
Original Publication Date: 
Apr 2019

Quality of response to immunosuppressive therapy and long-term outcomes for pediatric severe

Bone Marrow Diseases: 

Eltrombopag for refractory severe aplastic anemia: dosing, duration, long term outcomes and clonal evolution

Author(s): 
Winkler T, Fan X, Cooper J, Desmond R, Young DJ, Townsley DM, Scheinberg P, Grasmeder S, Larochelle A, Desierto M, Valdez J, Lotter J, Wu C, Shalhoub RN, Calvo KR, Young NS, Dunbar CE
Primary Author: 
Winkler T
Journal Title: 
Blood
Original Publication Date: 
Apr 2019

Bone Marrow Diseases: 

Jodi Mayfield, MD, MS

Mayfield, Jodi
Assistant Professor, Department of Pediatrics, Division of Pediatric Hematology & Oncology
University of New Mexico Comprehensive Cancer Center

Dr. Jodi Mayfield is an Assistant Professor of Pediatric Hematology/Oncology and Stem Cell research at the University of New Mexico. She received her MD from the University of New Mexico Health Sciences Center in 2008. She is currently a member of the American Society of Hematology and the Children's Oncology Group. Dr. Mayfield's areas of practice include Stem Cell transplantation, Acute Leukemias, and

Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry

Author(s): 
Lee JW, Peffault de Latour R, Brodsky RA, Jang JH, Hill A, Röth A, Schrezenmeier H, Wilson A, Marantz JL, Maciejewski JP.
Primary Author: 
Lee JW
Journal Title: 
Am J Hematol
Original Publication Date: 
Jan 2019

No abstract available

Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria.

Author(s): 
Escalante CP, Chisolm S, Song J, Richardson M, Salkeld E, Aoki E, Garcia-Manero G.
Primary Author: 
Escalante CP
Journal Title: 
Cancer Med
Original Publication Date: 
Feb 2019
BACKGROUND:

Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia

Author(s): 
Xu ZL, Zhou M, Jia JS, Mo WJ, Zhang XH, Zhang YP, Wang Y, Li YM, Huang XJ, Wang SQ, Xu LP
Primary Author: 
Xu Zi
Journal Title: 
Bone Marrow Transplant
Original Publication Date: 
Jan 2019
Our study aimed to compare treatment outcomes between hematopoietic stem cell transplantation (HSCT) from haploidentical donors (HID) and immunosuppressive therapy (IST) in adults with acquired severe
Bone Marrow Diseases: 

2019 March for Marrow 5K Run & Walk Los Angeles

Come celebrate the 10th Annual March for Marrow Los Angeles with Honorary Chair Connie Britton. Our 5K and Walk have the distinction of taking place along the beautiful stretch of shoreline that is part of the Long Beach Shoreline Marina. With the iconic Queen Mary in the background, the course is scenic, flat, and regardless of weather, ideal for beating one's personal best.

Event Date: 
Sat, 04/27/2019
Community Event Type: